References
- Anonymous. (1998). Efficacy and safety of highly purified urinary follicle-stimulating hormone with chorionic gonadotrophin for treating men with isolated hypogonadotrophic hypogonadism. European Metrodin HP Study Group. Fertility & Sterility, 70, 256–262.
- Buchter, D., Behre, H. M., Kliesch, S., Nieschlag, E. (1998). Pulsatile GnRH or human chorionic gonadotrophin/human menopausal gonadotrophin as effective treatment for men with hypogonadotrophic hypogonadism: a review of 42 cases. European Journal of Endocrinology, 139, 298–303.
- Burgues, S., Calderon, M. D. (1997). Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative group on Male Hypogonadotrophic Hypogonadism. Human Repoduction, 12, 980–986.
- Burris, A. S., Rodbard, H. W., Winters, S. J., Sherins, R. J. (1988). Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. Journal of Clinical Endocrinology & Metabolism, 66, 1144–1151.
- Finkel, D. M., Phillips, J. L., Snyder, P. J. (1985). Stimulation of spermatogenesis by gonadotrphins in men with hypogonadotrophic hypogonadism. New England Journal of Medicine, 313, 651–655.
- Hansen, M., Kurinczuk, J. J., Bower, C., Webb, S. (2002). The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. New England Journal of Medicine, 346, 725–730.
- Kretser, D. M., Baker, H. W. G. (1999). Infertility in men: recent advances and continuing controversies. Journal of Clinical Endocrinology & Metabolism, 84, 3443–3450.
- Kumanov, P., Nandipati, K., Tomova, A., Agarwal, A. (2006). Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertility & Sterility, 86, 332–338.
- Liu, P. Y., Gebski, V. J., Turner, L., Conway, A. J., Wishart, S. M., Handelsman, D. J. (2002). Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin deficient infertile men. Human Reproduction, 17, 625–633.
- Liu, P. Y., Turner, L., Rushford, D., McDonald, J., Baker, H. W., Conway, A. J., et al (1999). Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Human Reproduction, 14, 1540–1545.
- Matsumoto, A. M., Karpas, A. E., Bremner, W. J. (1986). Chronic human chorionic gonadotropin administration in normal men: evidence that follicle stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. Journal of Clinical Endocrinology & Metabolism, 62, 1184–1192.
- McLachlan, R. I. (2000). The endocrine control of spermatogenesis. Best practice and research. Journal of Clinical Endocrinology and Metabolism, 14, 345–362.
- Moudgal, N. R., Sairam, M. R. (1988). Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates? Human Reproduction, 13, 916–919.
- Natchtigall, L. B., Boepple, P. A., Pralong, F. P., Crowley, W. F. Jr. (1997). Adult-onset idiopathic hypogonadotrophic hypogonadism. A treatable form of male infertility. New England Journal of Medicine, 336, 410–415.
- Palermo, G., Joris, H., Devroey, P., Van Steirteghem, A. C. (1992). Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet, 340, 17–18.
- Pitteloud, N., Hayes, F. J., Dwyer, A., Boepple, P. A., Lee, H., Crowley, W. F. Jr. (2002). Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. Journal of Clinical Endocrinology & Metabolism, 87, 4128–4136.
- Plant, T. M., Marshall, G. R. (2001). The functional significanceof FSH in spermatogenesis and the control of its secretion in male primates. Endocrine Reviews, 22, 764–786.
- Schieve, L. A., Meikle, S. F., Ferre, C., Peterson, H. B., Jeng, G., Wilcox, L. S. (2002). Low and very low birth weight in infants conceived with use of assisted reproductive technology. New England Journal of Medicine, 346, 731–737.
- Sigman, M., Jarow, J. P. (1997). Endocrine evaluation of infertile men. Urology, 50, 659–664.
- Walsh, P. C., Retik A. B., Vaughan E. D., Wein A. J. (2002). Isolated hypogonadotrophic hypogonadism. Campbell's Urology, 3, 1500–1501.
- Winters, S. J. (1992). Expanding the differential diagnosis of male hypogonadism. New England Journal of Medicine, 326, 193–195.
- World Health Organization (WHO). (1999) Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge University Press, Cambridge, UK.
- Yong, E. L., Lee, K. O., Ng, S. C., Ratnam, S. S. (1997). Induction of spermatogenesis in isolated hypogonadotrophic hypogonadism with gonadotrophins and early intervention with intracytoplasmic sperm injection. Human Reproduction, 12, 1230–1232.
- Zorn, B., Pfeifer, M., Virant-Klun, I., Meden-Vrtovec, H. (2005). Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism. International Journal of Andrology, 28, 202–207.